Database: Additional databases on drug expenditure (France): Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
'''Primary purpose:''' Provides additional bases for medication expenses, enriched with beneficiary counts from all health insurance schemes in France. Offers insights into the number of people utilizing medications at various levels of grouping, along with indicators on amounts and box counts. | '''Primary purpose:''' Provides additional bases for medication expenses, enriched with beneficiary counts from all health insurance schemes in France. Offers insights into the number of people utilizing medications at various levels of grouping, along with indicators on amounts and box counts. | ||
'''Sponsor, manager or home institution:''' [[dataOwner::Caisse Nationale de l'Assurance Maladie (CNAM)]] [https://assurance-maladie.ameli.fr/]. | '''Sponsor, manager or home institution:''' [[dataOwner::Caisse Nationale de l'Assurance Maladie (CNAM)]]. [https://assurance-maladie.ameli.fr/ Click here to learn more]. | ||
'''Available type of information:''' [[hasDataDictionary::Open Medic: additional databases on drug expenditure]] [https://www.assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-depenses-beneficiaires-medicaments]. | '''Available type of information:''' [[hasDataDictionary::Open Medic: additional databases on drug expenditure]]. [https://www.assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-depenses-beneficiaires-medicaments Click here to learn more]. | ||
'''Source of Information:''' Système National des Données de Santé (SNDS) [https://assurance-maladie.ameli.fr/etudes-et-donnees/presentation-systeme-national-donnees-sante-snds]. | '''Source of Information:''' Système National des Données de Santé (SNDS). [https://assurance-maladie.ameli.fr/etudes-et-donnees/presentation-systeme-national-donnees-sante-snds Click here to learn more]. | ||
'''Available data level:''' [[availableDataLevel::regional level]]. | '''Available data level:''' [[availableDataLevel::regional level]]. | ||
'''Number of | '''Number of records:''' [[numberRecords::unknown]]. | ||
'''Date | '''Date range:''' [[dataStart::2014]] [[dataEnd::onwards]]. | ||
'''Cancer | '''Cancer areas of interest:''' [[hasCancerType::C00-D48: All neoplasms]]. [https://www.assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-depenses-beneficiaires-medicaments Click here to learn more]. | ||
'''Data access''': [[dataAvailability::publicly available]] [https://assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-depenses-beneficiaires-medicaments]. | '''Data access''': [[dataAvailability::publicly available]]. [https://assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-depenses-beneficiaires-medicaments Click here to access]. | ||
'''Contact information:''' Information [https://assurance-maladie.ameli.fr/etudes-et-donnees/en-savoir-plus-snds/utilisation-accompagnement-donnees-snds]. | '''Contact information:''' Information. [https://assurance-maladie.ameli.fr/etudes-et-donnees/en-savoir-plus-snds/utilisation-accompagnement-donnees-snds Click here to learn more]. | ||
Revision as of 00:16, 28 April 2024
Go back to France page
Primary purpose: Provides additional bases for medication expenses, enriched with beneficiary counts from all health insurance schemes in France. Offers insights into the number of people utilizing medications at various levels of grouping, along with indicators on amounts and box counts.
Sponsor, manager or home institution: Caisse Nationale de l'Assurance Maladie (CNAM). Click here to learn more.
Available type of information: Open Medic: additional databases on drug expenditure. Click here to learn more.
Source of Information: Système National des Données de Santé (SNDS). Click here to learn more.
Available data level: regional level.
Number of records: unknown.
Date range: 2014 onwards.
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Data access: publicly available. Click here to access.
Contact information: Information. Click here to learn more.
